Pharmaceutical manufacturers of Thioctic acid

OLON Group is a prominent worldwide firm specializing in the creation and manufacture of active pharmaceutical ingredients for CDMO and Generics. It serves as a dependable and preferred partner for the pharmaceutical, biotech, and specialty ingredients sectors. With a 2021 turnover of 580 million dollars, OLON provides 300 APIs for the Generic market. The company benefits from a workforce of 2,300 employees, including a highly skilled R&D team of over 300 individuals. This enables OLON to offer comprehensive integrated packages and services to facilitate the full development of APIs, leveraging extensive expertise in both Chemical and Biological processes, all within a full cGMP and regulatory framework. OLON holds approximately 160 active US DMFs and 79 granted CoS. OLON's headquarters is located in Rodano, near Milan, Italy, and it operates 11 manufacturing facilities - 8 in Italy, 1 in Spain, 1 in the USA, and 1 in India. These facilities are designed in accordance with the most stringent international standards. Additionally, OLON has 3 branch offices in Hamburg (Germany), Florham Park, NJ (USA), and Shanghai (China).

We, at TIEFENBACHER GROUP, are driven by a deep sense of purpose: we are pioneering healthcare to improve patients’ lives around the world. We believe that the access to affordable high quality-healthcare is a human right. We always challenge the status quo to be one step ahead – in terms of business models as well as concrete products and services. This entrepreneurial spirit is the driving force of making high-quality pharmaceuticals more affordable, more available, and better than before. 100% family owned since 1963, we are a purpose-driven healthcare company providing best-in-class solutions throughout the entire pharmaceutical value chain. From initial idea to market access: We distribute raw materials and develop, manufacture, and register finished dosage forms like tablets, capsules, powders, drops, and patches as well as medical devices. This broad competence enables us to pioneer healthcare holistically as we can connect ideas and expertise to create novel healthcare solutions. By working together as TIEFENBACHER GROUP, in agile collaboration and cross-functional structures, we tap into our full potential and stay at the forefront of our field.

Sinopharm, a significant healthcare organization affiliated with the State-owned Assets Supervision and Administration Commission (SASAC) of the State Council, operates with a workforce of 128,000 and a comprehensive industry presence encompassing research and development, production, supply chain management, retail outlets, medical services, engineering, events, international trade, and financial services. It possesses more than 1,100 subsidiaries and 6 publicly traded companies, including Sinopharm Group Co., Ltd. (Sinopharm Holding), China National Medicines Corporation Ltd., and China National Accord Medicines Corporation Ltd.

SCL was incorporated on December 20, 1993, as a Private Limited Company. Initially, it manufactured intermediates. On July 1, 1997, the company became a Public Limited Company and adopted its current name. In 2004, SCL established a new API manufacturing facility. Today, it offers a wide range of APIs and advanced intermediates in various therapeutic segments such as NSAIDs, cardiology, anti-cholinergic, CNS, anti-filarials, and anthelmintics, among others, to its customers. We are based in Panchkula, near Chandigarh, with two manufacturing facilities in Derabassi, Mohali (Punjab), for intermediates and APIs. The marketing office is located in Delhi NCR. We have acquired 22 acres of land for expanding facilities near the current site.

Established in the year 2000 as Dongwoo Shintech Co., Ltd., INIST ST has emerged as a pioneer in the advancement of pharmaceutical raw materials and the technology for synthesizing raw materials. Guided by the principles of transformation, innovation, and a passion for life, INIST ST has been engaged in the exploration and production of high-caliber generic raw materials and enhanced drugs through salt modification, commencing with the development of treatments for cerebrovascular diseases and distributing them both nationally and globally. Backed by unwavering trust and expertise, it is utilized as a contrast agent for heart disease and serves as the basis for numerous original active ingredients.

KINSY is an independent chemical company, located in Murcia (Spain), having broad expertise in development, scale-up and commercial production of fine chemicals, with a strong focus on development and manufacturing of key pharmaceutical intermediates and APIs under cGMP.

Jiangsu Tohope Pharmaceutical Co., Ltd is an innovative enterprise engaging in the research, development and production of APIs and Health Food Products, has more than 30 years chemical production experience, is the leading manufacturer of Alpha Lipoic Acid in China. We are deeply committed to the highest levels of quality, have well defined procedures and systems in place in compliance with the requirements of GMP. Meeting the needs of customers by providing the best quality products is our core principle.